FIGURE
Fig. 6
- ID
- ZDB-FIG-220719-66
- Publication
- Bär et al., 2022 - Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer
- Other Figures
- (all 13)
- All Figure Page
- Back to All Figure Page
Fig. 6
mRNA expression levels of HDACs 1-11 in untreated liver cancer cell lines HepG2 and Huh7. mRNA expression levels of HDACs 1-11 in liver cancer cell lines were measured using reverse transcription-quantitative PCR, which were then normalised to those of GAPDH, the housekeeping gene. Data are presented as the means ± SEM from three independent experiments. HDAC, histone deacetylase; Ctrl, control. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Int. J. Oncol.